Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clene Inc (NQ: CLNN )

2.730 +0.010 (+0.37%)
Streaming Delayed Price Updated: 11:34 AM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,415
Open 2.710
Bid (Size) 2.710 (3)
Ask (Size) 2.740 (6)
Prev. Close 2.720
Today's Range 2.650 - 2.835
52wk Range 1.930 - 17.82
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
Recap: Clene Q1 Earnings
Clene (NASDAQ:CLNN) reported its Q1 earnings results on Monday, May 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga

Performance

YTD
-38.24%
-38.24%
1 Month
+25.23%
+25.23%
3 Month
-16.26%
-16.26%
6 Month
-31.06%
-31.06%
1 Year
-75.52%
-75.52%

More News

Read More
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
93 Biggest Movers From Yesterday
Via Benzinga
Why Clene Shares Are Rising
Via Benzinga
81 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
Via Benzinga
Jonathan Heller Purchases 100,000 Shares Of CBL & Associates (CBL) And Other Insider Trades
Via Benzinga
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Via Benzinga
48 Biggest Movers From Yesterday
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Clene's Amyotrophic Lateral Sclerosis Candidate Shows Favorable Impact On Disease Progression
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
52 Biggest Movers From Yesterday
Via Benzinga
Exposures Product Safety
44 Biggest Movers From Yesterday
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
71 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.